TABLE 2.
Total n = 380 | UW n = 267 | CS n = 83 | HTK n = 7 | IGL-1 n = 23 | P | |
Age (years) | 32 (21–40) | 30 (20–39) | 37 (29–45) | 43 (33–47) | 30 (19–39) | 0.803a |
0.042b | ||||||
<0.001c | ||||||
Gender M/F | 224 (58.9)/156 (41.1) | 164 (61.4)/103 (38.6) | 45 (54.2)/38 (45.8) | 4 (57.1)/3 (42.9) | 11 (47.8)/12 (52.2) | 0.266a |
0.642b | ||||||
0.251c | ||||||
Cause of death | ||||||
-Trauma | 197 (51.8) | 153 (57.3) | 31 (37.3) | 2 (28.6) | 11 (47.8) | 0.561a |
-Anoxic damage | 21 (5.5) | 14 (5.2) | 5 (6) | - | 2 (8.7) | 0.100b |
-CVA | 146 (38.4) | 90 (33.7) | 44 (53) | 4 (57.1) | 8 (34.8) | 0.012c |
-Others | 16 (4.2) | 10 (3.7) | 3 (3.6) | 1 (14.3) | 2 (8.7) | |
BMI (kg/m2) | 23.4 (21.5–25.3) | 23.2 (21.3–25.2) | 23.4 (22.3 25.5) | 24.2 (23.1–27.3) | 23.6 (20.8–25.6) | 0.839a |
0.418b | ||||||
0.065c | ||||||
Pancreas CIT (hours) | 10.1 (8–12) | 10 (8–12) | 11 (9–12.1) | 8.3 (6–10.3) | 8.2 (7.1–10.1) | 0.001a |
<0.001b | ||||||
0.115c | ||||||
Kidney CIT (hours) | 12.3 (10–14.3) | 12.3 (10–14.3) | 12.8 (10.2–14.7) | 10.8 (9.4–14.1) | 11.2 (9.9–12.8) | 0.262a |
0.188b | ||||||
0.600c | ||||||
PPASS | 16 (14–18) | 16 (14–18) | 17 (14–18) | 17 (15–20) | 17 (14–18) | 0.637a |
0.683b | ||||||
0.043c | ||||||
Perfusion Volume (L) | 6.8 (6.0–7.4) | 6.5 (6.0–7.0) | 6 (5–6.1) | 7 (6–7.5) | 7.5 (7–8) | 0.014a |
0.002b | ||||||
0.099c | ||||||
Amylase (IU/L) | 84 (47–164.2) | 86 (48–172) | 73 (39–146) | 51 (39–63) | 94 (57–294) | 0.629a |
0.202b | ||||||
0.112c | ||||||
Lipase (IU/L) | 45 (17–109) | 50 (20–126) | 22 (11–85.5) | 29 (8.2–55.7) | 33 (6–79) | 0.088a |
0.820b | ||||||
0.091c |
Continuous variables are expressed as median (interquartile ranges) and categorical variables as frequencies (percentages).
Comparison of the analyzed variables have been made between UW, CS, and IGL-1, groups. For HTK, group only a descriptive analysis is displayed.
aIGL-1, vs. UW; bIGL-1, vs. CS; cUW, vs. CS.
M, indicates male; F, female; CVA, cerebrovascular accident; BMI, body mass index; CIT, cold ischemia time; PPASS, pre-procurement pancreas suitability score; UW, University of Wisconsin; CS, Celsior; HTK, Histidine-Tryptophan-Ketoglutarate; IGL-1, Institut Georges Lopez-1.